Inventor · disambiguated record
Henry A. Lardy
Also filed as: LARDY HENRY A
24 granted patents·4 pending applications·672 citations·filing 1992–2010
97Inventor score
Files withHUMANETICS CORP15HOLLIS EDEN PHARMACEUTICALS4AHLEM CLARENCE N1HARBOR BIOSCIENCES INC1HUMANETIC CORP1
Top patents by PatentIndex Score
28 records- 0197US7462610B2Prostate cancer treatmentHOLLIS EDEN PHARMACEUTICALS·Filed 2007·Granted Dec 9, 2008·36 cites·16 claims
- 0295US7842680B2Diene and triene compounds and formulationsHARBOR BIOSCIENCES INC·Filed 2009·Granted Nov 30, 2010·19 cites·17 claims
- 0393US7550450B2Prostate cancer treatmentHOLLIS EDEN PHARMACEUTICALS·Filed 2007·Granted Jun 23, 2009·12 cites·4 claims
- 0493US7514420B2Steroids having 1,8-unsaturation and formulations comprising sameHOLLIS EDEN PHARMACEUTICALS·Filed 2007·Granted Apr 7, 2009·19 cites·21 claims
- 0593US6924274B2Use of Δ5-androstene-3β-ol-7,17-dione in the treatment of lupus erythematosusHUMANETIC CORP·Filed 2003·Granted Aug 2, 2005·62 cites·9 claims
- 0690US5869709AProcess for effecting allylic oxidationHUMANETICS CORP·Filed 1997·Granted Feb 9, 1999·35 cites·19 claims
- 0788US5506223AΔ5-androstenes useful for promoting weight maintenance or weight loss and treatment processHUMANETICS CORP·Filed 1994·Granted Apr 9, 1996·50 cites·12 claims
- 0888US5292730AModulation of immune system with Δ5-androstenesHUMANETICS CORP·Filed 1992·Granted Mar 8, 1994·66 cites·4 claims
- 0986US5296481ATreatment process for promoting weight loss employing a substituted Δ5HUMANETICS CORP·Filed 1992·Granted Mar 22, 1994·65 cites·17 claims
- 1085US5424463AΔ5-androstenes useful for promoting weight maintenance or weight loss and treatment processHUMANETICS CORP·Filed 1994·Granted Jun 13, 1995·74 cites·6 claims
- 1182US6686486B1Process for effecting allylic oxidationFiled 2000·Granted Feb 3, 2004·12 cites·42 claims
- 1282US6111118AProcess for effecting allylic oxidationHUMANETICS CORP·Filed 1999·Granted Aug 29, 2000·19 cites·22 claims
- 1381US6274746B1Process for allylic oxidation using metal hypochlorite and alkyl hydroperoxideFiled 2000·Granted Aug 14, 2001·16 cites·20 claims
- 1481US5585371ATreatment of immune system with Δ5-androstenesHUMANETICS CORP·Filed 1994·Granted Dec 17, 1996·61 cites·4 claims
- 1575US6593316B2Use of Δ5-androstene-3βol-7,17-dione in the treatment of lupus erythematosusFiled 2002·Granted Jul 15, 2003·4 cites·20 claims
- 1672US6489313B1Memory by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β estersHUMANETICS CORP·Filed 2000·Granted Dec 3, 2002·7 cites·48 claims
- 1768US7638509B2Diene compounds and formulationsHOLLIS EDEN PHARMACEUTICALS·Filed 2009·Granted Dec 29, 2009·0 cites·20 claims
- 1868US6384251B1Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagentsHUMANETICS CORP·Filed 1999·Granted May 7, 2002·19 cites·19 claims
- 1967US5641766AUP-regulation of immune system with Δ 5-AndrostenesHUMANETICS CORP·Filed 1995·Granted Jun 24, 1997·29 cites·4 claims
- 2061US5707983ATreatment of alzheimer's disease and modulation of immune system with Δ5-androstenesHUMANETICS CORP·Filed 1997·Granted Jan 13, 1998·21 cites·20 claims
- 2160US6372732B1Use of delta5-androstene-3beta-ol-7, 17-dione in the treatment of lupus erythematosusHUMANETICS CORP·Filed 1998·Granted Apr 16, 2002·12 cites·26 claims
- 2259US2011028711A1Unsaturated Steroid CompoundsLARDY HENRY A·Filed 2010·Application pending·0 cites
- 2354US2004242618A1Antiandrogens with marginal agonist activity and methods of useFiled 2004·Application pending·0 cites
- 2453US2006079492A1Compositions and treatment methodsAHLEM CLARENCE N·Filed 2005·Application pending·0 cites
- 2551US5807848AUse of dehydroepeiandrosterone-3-carboxylates to control body weightHUMANETICS CORP·Filed 1996·Granted Sep 15, 1998·12 cites·39 claims
- 2648US5885977AUse of Δ5 androstenes in the treatment of HIV wasting syndromeHUMANETICS CORP·Filed 1997·Granted Mar 23, 1999·12 cites·27 claims
- 2747US6153606AMemory enhancement by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β esters thereofHUMANETICS CORP·Filed 1998·Granted Nov 28, 2000·10 cites·6 claims
- 2841US2003083231A1Blood cell deficiency treatment methodFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henry A. Lardy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →